SVB Wealth’s Amphastar Pharmaceuticals AMPH Stock Holding History

SVB Wealth’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34	Closed	-$986	–	510
2025 Q1	$986	Buy	+34	New	+$1.09K	﹤0.01%	1353

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

SVB Wealth's AMPH Position: Q2 2025 in Review

SVB Wealth sold out of Amphastar Pharmaceuticals (AMPH) in Q2 2025, closing a stake of 34 shares — an estimated $986 sold.

SVB Wealth first reported a position in AMPH in Q1 2025 and held it in 1 quarter. The position peaked at $986 in Q1 2025. 245 funds tracked by Wall St. Rank hold AMPH as of Q2 2025.

SVB Wealth reported no remaining Amphastar Pharmaceuticals position as of Q2 2025 after selling out during the quarter.
SVB Wealth sold 34 Amphastar Pharmaceuticals shares in Q2 2025, an estimated $986.
SVB Wealth first reported a position in Amphastar Pharmaceuticals in Q1 2025 and held it in 1 quarter.
SVB Wealth's Amphastar Pharmaceuticals position peaked at $986 in Q1 2025.
245 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q2 2025.

Based on SVB Wealth's 13F filing for Q2 2025, filed 14 Aug 2025.